Global Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Research Report 2024

Publication ID:

PB508246108

Publication Date:

August 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Pharmaceutical grade liquid carbon dioxide is a high-purity form of CO2 produced through a strict purification process to meet pharmaceutical standards. It undergoes quality control measures, often includes certifications for compliance with pharmacopeial standards, and may undergo sterilization. The production and distribution comply with regulatory requirements, and comprehensive documentation ensures traceability. Its applications in pharmaceutical manufacturing, research and development, aseptic processing, and medical applications contribute to the production of pharmaceutical products while meeting industry regulations and standards.
The global Pharmaceutical Grade Liquid Carbon Dioxide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pharmaceutical Grade Liquid Carbon Dioxide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharmaceutical Grade Liquid Carbon Dioxide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pharmaceutical Grade Liquid Carbon Dioxide include Linde Gas, Air Products, Matheson, SOL, Nippon Gases, CalOx, Carbacid, Universal Industrial Gses and Kaimeite Gases, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Liquid Carbon Dioxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Liquid Carbon Dioxide.
Report Scope
The Pharmaceutical Grade Liquid Carbon Dioxide market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Grade Liquid Carbon Dioxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Liquid Carbon Dioxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Linde Gas
Air Products
Matheson
SOL
Nippon Gases
CalOx
Carbacid
Universal Industrial Gses
Kaimeite Gases
Segment by Type
0.999
0.9995
0.9999
Others
Segment by Application
Pharmaceutical Manufacturers
Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Liquid Carbon Dioxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Grade Liquid Carbon Dioxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Overview
1.1 Product Overview and Scope of Pharmaceutical Grade Liquid Carbon Dioxide
1.2 Pharmaceutical Grade Liquid Carbon Dioxide Segment by Type
1.2.1 Global Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 0.999
1.2.3 0.9995
1.2.4 0.9999
1.2.5 Others
1.3 Pharmaceutical Grade Liquid Carbon Dioxide Segment by Application
1.3.1 Global Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Value by Application: (2024-2030)
1.3.2 Pharmaceutical Manufacturers
1.3.3 Laboratory
1.4 Global Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue 2019-2030
1.4.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales 2019-2030
1.4.3 Global Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Competition by Manufacturers
2.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Average Price by Manufacturers (2019-2024)
2.4 Global Pharmaceutical Grade Liquid Carbon Dioxide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Grade Liquid Carbon Dioxide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Grade Liquid Carbon Dioxide, Product Type & Application
2.7 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Competitive Situation and Trends
2.7.1 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Grade Liquid Carbon Dioxide Players 麻豆原创 Share by Revenue
2.7.3 Global Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Grade Liquid Carbon Dioxide Retrospective 麻豆原创 Scenario by Region
3.1 Global Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Region: 2019-2030
3.2.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Region: 2019-2024
3.2.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Region: 2025-2030
3.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Region: 2019-2030
3.3.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Region: 2019-2024
3.3.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Region: 2025-2030
3.4 North America Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Facts & Figures by Country
3.4.1 North America Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharmaceutical Grade Liquid Carbon Dioxide Sales by Country (2019-2030)
3.4.3 North America Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Facts & Figures by Country
3.5.1 Europe Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharmaceutical Grade Liquid Carbon Dioxide Sales by Country (2019-2030)
3.5.3 Europe Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharmaceutical Grade Liquid Carbon Dioxide Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharmaceutical Grade Liquid Carbon Dioxide Sales by Country (2019-2030)
3.7.3 Latin America Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharmaceutical Grade Liquid Carbon Dioxide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Type (2019-2030)
4.1.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Type (2019-2030)
4.2.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Application (2019-2030)
5.1.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Application (2019-2030)
5.2.1 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Pharmaceutical Grade Liquid Carbon Dioxide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Linde Gas
6.1.1 Linde Gas Corporation Information
6.1.2 Linde Gas Description and Business Overview
6.1.3 Linde Gas Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Linde Gas Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.1.5 Linde Gas Recent Developments/Updates
6.2 Air Products
6.2.1 Air Products Corporation Information
6.2.2 Air Products Description and Business Overview
6.2.3 Air Products Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Air Products Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.2.5 Air Products Recent Developments/Updates
6.3 Matheson
6.3.1 Matheson Corporation Information
6.3.2 Matheson Description and Business Overview
6.3.3 Matheson Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Matheson Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.3.5 Matheson Recent Developments/Updates
6.4 SOL
6.4.1 SOL Corporation Information
6.4.2 SOL Description and Business Overview
6.4.3 SOL Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SOL Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.4.5 SOL Recent Developments/Updates
6.5 Nippon Gases
6.5.1 Nippon Gases Corporation Information
6.5.2 Nippon Gases Description and Business Overview
6.5.3 Nippon Gases Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nippon Gases Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.5.5 Nippon Gases Recent Developments/Updates
6.6 CalOx
6.6.1 CalOx Corporation Information
6.6.2 CalOx Description and Business Overview
6.6.3 CalOx Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CalOx Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.6.5 CalOx Recent Developments/Updates
6.7 Carbacid
6.6.1 Carbacid Corporation Information
6.6.2 Carbacid Description and Business Overview
6.6.3 Carbacid Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Carbacid Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.7.5 Carbacid Recent Developments/Updates
6.8 Universal Industrial Gses
6.8.1 Universal Industrial Gses Corporation Information
6.8.2 Universal Industrial Gses Description and Business Overview
6.8.3 Universal Industrial Gses Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Universal Industrial Gses Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.8.5 Universal Industrial Gses Recent Developments/Updates
6.9 Kaimeite Gases
6.9.1 Kaimeite Gases Corporation Information
6.9.2 Kaimeite Gases Description and Business Overview
6.9.3 Kaimeite Gases Pharmaceutical Grade Liquid Carbon Dioxide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kaimeite Gases Pharmaceutical Grade Liquid Carbon Dioxide Product Portfolio
6.9.5 Kaimeite Gases Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Grade Liquid Carbon Dioxide Industry Chain Analysis
7.2 Pharmaceutical Grade Liquid Carbon Dioxide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Grade Liquid Carbon Dioxide Production Mode & Process
7.4 Pharmaceutical Grade Liquid Carbon Dioxide Sales and 麻豆原创ing
7.4.1 Pharmaceutical Grade Liquid Carbon Dioxide Sales Channels
7.4.2 Pharmaceutical Grade Liquid Carbon Dioxide Distributors
7.5 Pharmaceutical Grade Liquid Carbon Dioxide Customers
8 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Dynamics
8.1 Pharmaceutical Grade Liquid Carbon Dioxide Industry Trends
8.2 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Drivers
8.3 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Challenges
8.4 Pharmaceutical Grade Liquid Carbon Dioxide 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Linde Gas
Air Products
Matheson
SOL
Nippon Gases
CalOx
Carbacid
Universal Industrial Gses
Kaimeite Gases

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.